Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 258.50
Bid: 258.00
Ask: 259.00
Change: 8.00 (3.19%)
Spread: 1.00 (0.388%)
Open: 252.00
High: 261.00
Low: 251.00
Prev. Close: 250.50
CMCX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to ASIC consultation paper

22 Aug 2019 11:52

RNS Number : 9455J
CMC Markets Plc
22 August 2019
 

22 August 2019

CMC Markets Plc

Response to ASIC consultation paper and update on current trading

 

CMC Markets plc ("CMC") notes the announcement by the Australian Securities and Investments Commission ("ASIC") issued today regarding a consultation on the application of product intervention powers on the issuance and distribution of binary options and contracts for difference to retail clients.

In its consultation paper, ASIC are seeking industry comment on the proposed introduction of regulatory changes, covering binary options, leverage ratio limits, margin close-out, negative balance protection, inducements and disclosure. The changes proposed are similar to that already implemented in other jurisdictions, including ESMA. ASIC is required to consult with the industry before making a product intervention order. Any product intervention order which ASIC makes is only effective for up to an initial period of 18 months.

Fair outcomes for clients have always been a focus for CMC. Benefitting from its proprietary technology and focus on targeting higher valued experienced clients, CMC is well prepared to respond quickly and manage any regulatory changes as required.

CMC noted in its Q1 Trading Update on 25 July 2019 that the imposition of limits by ESMA had resulted in a period of transition, where clients adjusted their trading behaviour to the new environment and CMC adjusted its model accordingly. Following the stabilisation noted in the Q1 update, the Board is pleased to see that net operating income has performed strongly through the summer.

Australia is an important part of CMC's balanced and diverse portfolio of regions and products, with a large non-leveraged stockbroking business and a leveraged CFD business aimed at more sophisticated investors. In the last financial year ended 31 March 2019, the Australian business as a whole represented 31% of the Group's net operating income. Within that, CFD net revenue constituted 20% of Group CFD (and Spread bet) net revenue and 17% of the Group's net operating income.

CMC values regular and transparent dialogue with regulators. Key to this dialogue is CMC's belief in a consistent approach to regulation, a level playing field, and raising standards in the industry. CMC will continue to engage with ASIC over the coming months and will harness the experience gained from recent UK and European regulatory changes when responding and adapting to any measures implemented by ASIC.

Outlook

On the basis of recent and current trading as noted above, the Board believes that CMC is currently on track to report net operating income and Profit Before Tax for the year ended 31 March 2020 that is marginally ahead of the upper end of the current range of analysts' forecasts.1,2

Forward looking statements

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

 

Enquiries

 

CMC Markets Plc +44 (0) 20 7170 8200

Euan Marshall, Interim Chief Financial Officer

 

Camarco +44 (0) 20 3757 4980

Geoffrey Pelham-Lane

Ed Gascoigne-Pees

Jennifer Renwick

 

Notes to Editors

 

1. The range of publicly available analysts' forecasts for net operating income for 2020 is £149.2m to £159.6m, with a mean of £154.0m based on company compiled consensus as at the date of this announcement.

2. The range of publicly available analysts' forecasts for Profit Before Tax for 2020 is £23.4m to £26.3m, with a mean of £24.6m based on company compiled consensus as at the date of this announcement.

 

About CMC Markets plc

CMC Markets plc, whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 13 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPUUSRRKBAWUAR
Date   Source Headline
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement
21st Jul 202311:20 amRNSDirector/PDMR Shareholding
21st Jul 202310:07 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
7th Jul 202310:09 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSDirectorate Change
23rd Jun 20235:09 pmRNSNotice of AGM
13th Jun 20237:00 amRNSFinal Results
9th Jun 20237:00 amRNSInvestment in StrikeX Technologies
6th Jun 20231:48 pmRNSDirector/PDMR Shareholding
9th May 20231:34 pmRNSDirector/PDMR Shareholding
6th Apr 20233:40 pmRNSDirector/PDMR Shareholding
31st Mar 202310:56 amRNSHolding(s) in Company
27th Mar 20233:51 pmRNSTrading Statement
7th Mar 20232:49 pmRNSDirector/PDMR Shareholding
7th Feb 202311:37 amRNSDirector/PDMR Shareholding
25th Jan 20237:00 amRNSTrading Statement
9th Jan 20232:15 pmRNSDirector/PDMR Shareholding
9th Jan 202312:50 pmRNSDirector/PDMR Shareholding
6th Jan 20233:22 pmRNSDirector/PDMR Shareholding
14th Dec 202212:38 pmRNSDirectorate Change
6th Dec 20222:38 pmRNSDirector/PDMR Shareholding
21st Nov 20221:54 pmEQSCMC Markets 'to continue rolling out investment platform'

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.